Search for: "WATSON PHARMACEUTICALSÂ "
Results 261 - 280
of 359
Sorted by Relevance
|
Sort by Date
4 Nov 2009, 4:03 am
(IP finance) Brazil: BPTO v ANVISA (Health National Surveillance Agency): Pharmaceutical patents in Brazil (IP tango) Canada finds patents no help for poorest in need of medicine (IP Watch) Ecuador grants obligatory patent licenses (IP tango) (IP tango) (IP tango) India: Glenmark Pharmaceuticals and Suven Life Sciences: The new face of the innovating ‘Indian’ pharma industry? [read post]
1 Apr 2013, 8:29 am
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
4 Nov 2009, 4:03 am
(IP finance) Brazil: BPTO v ANVISA (Health National Surveillance Agency): Pharmaceutical patents in Brazil (IP tango) Canada finds patents no help for poorest in need of medicine (IP Watch) Ecuador grants obligatory patent licenses (IP tango) (IP tango) (IP tango) India: Glenmark Pharmaceuticals and Suven Life Sciences: The new face of the innovating 'Indian' pharma industry? [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
15 Jun 2011, 4:56 am
Watson Pharmaceuticals, Inc. et al. [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb)… [read post]
15 May 2011, 2:54 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V. notifying them that the Bureau believes the companies violated federal law by failing to inform antitrust authorities about patent agreements involving Sanofi’s insomnia drug AMBIEN CR (zolpidem tartrate) Tablets, but that instead of recommending that the FTC take enforcement action, it would issue advisory letters. [read post]
18 Oct 2011, 1:32 am
Everyone in the industry benefits from Towers Watson’s annual survey, the summary report for which Tower Watson makes freely available. [read post]
23 Sep 2010, 12:39 pm
Karst – On September 22, 2010, Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]
13 Sep 2011, 3:48 am
” The Towers Perrin / Towers Watson study, the sole source of most of these claims, remains discredited. [read post]
15 Feb 2011, 5:26 pm
: Ineos Healthcare v OHMI – Teva (Class 46) Androderm (Testosterone) – US: Watson settles with Promote Innovation in Androderm false marking suit (Patent Docs) Asacol (Mesalamine) – US: Roxane sanctioned in Asacol patent dispute with Medeva (Patent Docs) Detrol (Tolterodine) – US: Subsequent ANDA sponsor says Detrol LA patent has gotta go; But would a final court decision trigger 180-day exclusivity? [read post]
17 Feb 2009, 2:40 am
For example, the DNA sequence of James Watson, who helped discover DNA, was found to possess a sequence for Alzheimer’s. [read post]
17 Nov 2010, 1:48 am
General Where in the world is pharmaceutical innovation? [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense to Walker… [read post]
27 Sep 2010, 12:59 am
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
19 Oct 2010, 10:42 pm
General WTO paragraph 6 meeting aims at improved use of health waiver (IP Watch) The absence of investment in new antibiotics (IPBiz) Integration of intellectual property and regulatory exclusivity strategies for life science companies (IP Spotlight) Pharmaceutical companies can innovate if they want to (profitability through simplicity) Medicines Patent Pool seeks business director (IP Watch) WHO moves IP, innovation out of Director General’s office (IP Watch) A rights-poor… [read post]
19 Mar 2021, 6:37 am
” Our software will ensure patients receive not only the best treatment possible but personalized pharmaceutical and treatment plans benchmarked using data, rather than depending on the individual experience of a particular physician or group. [read post]
20 Dec 2013, 6:36 am
William Watson, Trade Policy Analyst, Herbert A. [read post]
23 Nov 2010, 2:19 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
